Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)
Dietary Changes Limit sulphur-rich foods (eggs, broccoli, sprouts, garlic, onions)
Increased Energy Expenditure Some GLP-1 medications have been shown to increase energy expenditure, potentially further contributing to weight loss
These behavioral changes, combined with consistent physical activity (150+ minutes per week of moderate exercise), create a metabolic foundation that persists even after the medication ends
We need to prove that there is a long term health benefit for patients and the healthcare system
It is acceptable to delay your injection by one to three days until GI symptoms from the illness resolve